Literature DB >> 21824168

HIV-1 evolution in relation to molecular epidemiology and antiretroviral resistance.

Helena Skar1, Charlotte Hedskog, Jan Albert.   

Abstract

HIV/AIDS has become one of the most important infectious diseases with a cumulative number of almost 60 million infections worldwide. The prevalence and epidemiological patterns are unevenly distributed across the globe and also within countries. HIV is one of the fastest evolving organisms known. Several genetically distinct subtypes are present and new circulating recombinant forms are continuously emerging. This review discusses HIV-1 evolution in relation to molecular epidemiology and antiretroviral resistance. Factors and concepts that influence global spread and within-patient evolution of HIV-1 are discussed as well as future perspectives on the use of phylodynamics in HIV epidemiology.
© 2011 New York Academy of Sciences.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21824168     DOI: 10.1111/j.1749-6632.2011.06128.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  5 in total

Review 1.  The emergence of drug resistant HIV variants and novel anti-retroviral therapy.

Authors:  Koosha Paydary; Parisa Khaghani; Sahra Emamzadeh-Fard; Seyed Ahmad Seyed Alinaghi; Kazem Baesi
Journal:  Asian Pac J Trop Biomed       Date:  2013-07

Review 2.  Phylogenetic inferences on HIV-1 transmission: implications for the design of prevention and treatment interventions.

Authors:  Bluma Brenner; Mark A Wainberg; Michel Roger
Journal:  AIDS       Date:  2013-04-24       Impact factor: 4.177

Review 3.  Respiratory virus modulation of host nucleocytoplasmic transport; target for therapeutic intervention?

Authors:  Leon Caly; Reena Ghildyal; David A Jans
Journal:  Front Microbiol       Date:  2015-08-14       Impact factor: 5.640

4.  HIV-1 diversity, drug-resistant mutations, and viral evolution among high-risk individuals in phase II HIV vaccine trial sites in southern China.

Authors:  Haiyan Qi; Ke Zhao; Fei Xu; Xuzhao Zhang; Zhiyong Zhang; Li Yang; Chunling Li; Xu Liang; Weigui Guo; Shihai Chen; Zhihao Liu; Wenyan Zhang; Xiao-Fang Yu
Journal:  PLoS One       Date:  2013-07-15       Impact factor: 3.240

5.  HIV-1 diversity and drug-resistant mutations in infected individuals in Changchun, China.

Authors:  Ming Yan; Ke Zhao; Juan Du; Linzhang Li; Donglin Wu; Shengming Xu; Xiangchao Zeng; Guanjun Wang; Xiao-Fang Yu
Journal:  PLoS One       Date:  2014-06-19       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.